Rachel Mayo to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications Rachel Mayo has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.316
-
Factors associated with longer endocrine therapy use by South Carolina Medicaid-insured breast cancer survivors. J Oncol Pharm Pract. 2020 Jan; 26(1):36-42.
Score: 0.162
-
Endocrine therapy use in the twenty-first century: usage rates and temporal trends illustrate opportunities for improvement for South Carolina Medicaid women. Breast Cancer Res Treat. 2018 Oct; 171(3):759-765.
Score: 0.154